Molecular determinants of progression and treatment response in melanoma

黑色素瘤是一种色素细胞的皮肤恶性肿瘤，是澳大利亚的主要健康问题，也是年轻人最常见的癌症。该项目利用世界上最大的黑色素瘤治疗服务机构的资源，旨在为1)改善对黑色素瘤进展的高风险个人的管理，以及2)改善对早期和播散性黑色素瘤患者的治疗，在成功治疗这种危险的癌症的前景迅速变化的时代，开发科学基础。

Melanoma, a skin malignancy of pigment cells, is a major Australian health problem and is the commonest cancer in young adults. This project utilises the resources of the world’s largest melanoma treatment service and aims to develop a scientific basis for 1) improved management of individuals at high risk for melanoma progression, and 2) improved treatment of patients with early and disseminated melanoma, in an era of rapid change in the prospects of successfully treating this dangerous cancer.